AIDS and the conundrum of jobLEDERMAN, M. M.The American journal of medicine. 1992, Vol 92, Num 6, pp 679-680, issn 0002-9343Article

Host-directed and immune-based therapies for human immunodeficiency virus infectionLEDERMAN, M. M.Annals of internal medicine. 1995, Vol 122, Num 3, pp 218-222, issn 0003-4819Article

Defective postbinding lysis underlies the impaired natural killer activityin factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacsKATZMAN, M; LEDERMAN, M. M.The Journal of clinical investigation. 1986, Vol 77, Num 4, pp 1057-1062, issn 0021-9738Article

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapySMITH, K. Y; VALDEZ, H; LEDERMAN, M. M et al.The Journal of infectious diseases. 2000, Vol 181, Num 1, pp 141-147, issn 0022-1899Article

Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic responseCONNICK, E; LEDERMAN, M. M; ROUSSEAU, F et al.The Journal of infectious diseases. 2000, Vol 181, Num 1, pp 358-363, issn 0022-1899Article

Lymphocyte proliferation assays may underestimate antigen responsiveness in human immunodeficiency virus infectionPATKI, A. H; PURVIS, S. F; MEYERSON, H. J et al.Clinical immunology (Orlando, Fla. Print). 1999, Vol 93, Num 3, pp 245-249, issn 1521-6616Article

Bacterial antigen activation of Vδ1 and Vδ2 γδ T cells of persons infected with human immunodeficiency virus type 1CHERVENAK, K. A; LEDERMAN, M. M; BOOM, W. H et al.The Journal of infectious diseases. 1997, Vol 175, Num 2, pp 429-433, issn 0022-1899Article

Human immunodeficiency virus type 1 activation after blood transfusionMUDIDO, P. M; GEORGES, D; DORAZIO, D et al.Transfusion (Philadelphia, PA). 1996, Vol 36, Num 10, pp 860-865, issn 0041-1132Article

Lymphocytes of persons with the acquired immunodeficiency syndrome and related conditions express reactivity with the monoclonal antibody 4D12 reflective of in vivo lymphocyte activationLEDERMAN, M. M; CAREY, J. T; SCHACTER, B et al.Human immunology. 1987, Vol 20, Num 4, pp 279-291, issn 0198-8859Article

Immune restoration with antiretroviral therapies : Implications for clinical managementLEDERMAN, M. M; VALDEZ, H; MD et al.JAMA, the journal of the American Medical Association. 2000, Vol 284, Num 2, pp 223-228, issn 0098-7484Article

Fibronectin and cellular cytotoxicity: evidence against a role for fibronectin in natural killer activityKATZMAN, M; LEDERMAN, M. M; SPAGNUOLO, P. J et al.The Journal of laboratory and clinical medicine. 1987, Vol 110, Num 1, pp 75-82, issn 0022-2143Article

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy : Relationships to host factors, cellular restoration, and virologic end pointsHULIN WU; KURITZKES, D. R; SPRITZLER, J et al.The Journal of infectious diseases. 1999, Vol 179, Num 4, pp 799-807, issn 0022-1899Article

A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrheaCOOPER, G. S; LEDERMAN, M. M; SALATA, R. A et al.The American journal of gastroenterology. 1996, Vol 91, Num 1, pp 80-84, issn 0002-9270Article

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeterHAMMER, S. M; KATZENSTEIN, D. A; HIRSCH, M. S et al.The New England journal of medicine. 1996, Vol 335, Num 15, pp 1081-1090, issn 0028-4793Article

L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chainLEDERMAN, M. M; GEORGES, D; DANDO, S et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1995, Vol 8, Num 2, pp 107-115, issn 1077-9450Article

Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virusLEDERMAN, M. M; GEORGES, D. L; KUSNER, D. J et al.Journal of acquired immune deficiency syndromes. 1994, Vol 7, Num 7, pp 727-733, issn 0894-9255Article

Suppression of interleukin-2 and interleukin-2 receptor expression in jurkat cells stably expressing the human immunodeficiency virus tat proteinPURVIS, S. F; GEORGES, D. L; WILLIAMS, T. M et al.Cellular immunology (Print). 1992, Vol 144, Num 1, pp 32-42, issn 0008-8749Article

A prospective study of human immunodeficiency cirus type 1 infection and the development of AIDS in subjects with hemophiliaGOEDERT, J. J; KESSLER, C. M; RAGNI, M. V et al.The New England journal of medicine. 1989, Vol 321, Num 17, pp 1141-1148, issn 0028-4793, 8 p.Article

Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factorCAREY, J. T; LEDERMAN, M. M; ZAHRA TOOSSI et al.JAMA, the journal of the American Medical Association. 1987, Vol 257, Num 5, pp 651-655, issn 0098-7484Article

Molluscum contagiosum and the acquired immunodeficiency syndrome: clinical and immunological details of two casesKATZMAN, M; CAREY, J. T; ELMETS, C. A et al.British journal of dermatology (1951). 1987, Vol 116, Num 1, pp 131-138, issn 0007-0963Article

Presence of antibodies to Mycoplasma pneumoniae in patients with bacterial meningitisLEDERMAN, M. M; ELLNER, J. J; KLEEMOLA, M et al.The Journal of infectious diseases. 1983, Vol 148, Num 2, pp 363-365, issn 0022-1899Article

Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individualsANTHONY, D. D; UMBLEJA, T; ABERG, J. A et al.Vaccine. 2011, Vol 29, Num 19, pp 3558-3563, issn 0264-410X, 6 p.Article

Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS : A Randomized, Double-Blind, Placebo-Controlled TrialBENSON, C. A; WILLIAMS, P. L; REICHMAN, R. C et al.The Journal of infectious diseases. 2000, Vol 181, Num 4, pp 1289-1297, issn 0022-1899Article

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir : Genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS Clinical Trials Group Protocol 315KURITZKES, D. R; SEVIN, A; LEDERMAN, M. M et al.The Journal of infectious diseases. 2000, Vol 181, Num 2, pp 491-497, issn 0022-1899Article

Effects of mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons : Results of AIDS Clinical Trials Group Protocol 853MACARTHUR, R. D; LEDERMAN, M. M; BENSON, C. A et al.The Journal of infectious diseases. 2000, Vol 181, Num 4, pp 1486-1490, issn 0022-1899Article